Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Kadmon acquires anticancer candidate from Concordia Pharmaceuticals

Jan. 12, 2012

Forma Therapeutics enters into exclusive alliance

Jan. 12, 2012

Akinion begins treatment in phase I/II AKN-028 study

Jan. 12, 2012

Guilin Sanjin Pharmaceutical claims novel saponins

Jan. 12, 2012

Chinese company patents new receptor tyrosine kinase inhibitors

Jan. 12, 2012

Japanese study supports in vivo antitumor activity of Golgi-disrupting agent

Jan. 12, 2012

Adherex continues enrollment in phase II eniluracil regimen study

Jan. 11, 2012

BKM-120 assessed as monotherapy and in combination regimens in metastatic breast cancer

Jan. 11, 2012

Phase II trial investigates effects of axitinib in metastatic melanoma

Jan. 11, 2012

Novel estrogen receptor-alpha modulators prepared by Aragon Pharmaceuticals

Jan. 10, 2012

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...